Welfare of Animals Used in Product Safety Testing — Regulatory Context

Regulatory requirements for product safety testing continue to require animal use in some sectors, but significant progress toward replacement has been made.

Key Facts

The EU banned animal testing for cosmetics in 2013 — products cannot be sold in the EU if tested on animals anywhere
Animal testing for pharmaceuticals remains required by regulatory agencies in most countries including the FDA and EMA
Non-animal testing methods (organoids, organ-on-chip, computer modelling) are advancing rapidly but not yet fully validated
The US FDA Modernization Act 2022 removed the legal requirement for animal tests in drug development — an option now, not a mandate
Rabbits are commonly used in Draize eye irritancy tests — alternatives including reconstructed human cornea models are available
LD50 tests (determining lethal dose in 50% of animals) have been largely replaced but are still used in some regulatory contexts
Industry investment in alternatives is insufficient — public funding of replacement method development is critical

Welfare Considerations

Regulatory animal testing represents a welfare problem embedded in legal requirements rather than producer choice. Progress requires both developing validated replacement methods and changing regulations to accept them. The EU cosmetics ban demonstrated that consumer demand and regulatory reform can eliminate an entire category of animal testing. The FDA Modernization Act is transformative — making animal tests optional where alternatives exist rather than mandatory. The remaining challenge is validating replacement methods to the standard regulators require, which needs sustained public investment in alternatives research. Individual consumers can drive change by supporting cruelty-free certified brands.

What You Can Do

Choose certified cruelty-free cosmetics, household products, and personal care items
Support organisations funding replacement method development like NC3Rs and FRAME
Advocate for regulatory acceptance of validated non-animal testing methods
Engage with your legislators about animal testing reform in drug development regulation
Support brands that invest in and advocate for replacement testing technologies